[ 6 ] Skerjanec A, Berenson J, Hsu C, et al. The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function[J]. J Clin Pharmacol, 2007, 43(2): 154-162.
[7]
[ 7 ] King AE, Umland Em. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates[J]. Pharmacotherapy, 2008, 28(5): 667-677.